Cardiac involvement and myocardial inflammation are common in recovered COVID-19 patients, according to a new study published in JAMA Cardiology.

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here? 

The peptide-derived drug, M3mP6 HLPN, prevents blood clots without increasing the risk of bleeding. 

The team found that approximately one in seven heart scans revealed abnormalities expected to “have a major effect” on the patient’s survival and recovery.

COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. 

The researchers tracked infection rates at Boston’s Mass General Brigham health system, which announced a plan to require all 78,000 employees to wear a surgical mask in March.

Nearly 600 hospitals were considered for this updated ranking. 

Two separate research teams have highlighted the benefits of limiting meat consumption and adopting a plant-based diet. 

ELVIS, it seems, has entered the operating room. 

The news comes just days after Major League Baseball began its pandemic-shortened season.